mass cytometry
Showing 26 - 50 of 6,070
Granulosa Cell DNA Damage in Success of Assisted Reproductive
Not yet recruiting
- DNA Damage
- Granulosa Cells
- (no location specified)
Sep 24, 2022
Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)
Recruiting
- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Natural Killer Cells
- +4 more
-
Columbus, OhioNationwide Children's Hospital
Oct 26, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Louisville (Beta-Glucan)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Beta-Glucan
-
Louisville, KentuckyUniversity of Louisville
Jan 7, 2022
Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)
Recruiting
- Psoriasis
- Atopic Dermatitis
- UVB treatment
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 24, 2022
Asthma; Eosinophilic Trial (Mepolizumab 100 MG)
Recruiting
- Asthma
- Eosinophilic Asthma
- Mepolizumab 100 MG
-
Ferrol, A Coruña, Spain
- +4 more
Sep 5, 2022
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
- Defactinib
-
Sydney, New South Wales, Australia
- +3 more
Jan 12, 2023
CKD (Chronic Kidney Disease) Stage 5D Trial (Sodium propionate, Placebo)
Not yet recruiting
- CKD (Chronic Kidney Disease) Stage 5D
- Sodium propionate
- Placebo
- (no location specified)
May 4, 2023
Blastoid Variant Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Follicular Lymphoma Trial in United
Active, not recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +8 more
- Ibrutinib
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +4 more
May 10, 2022
Intrinsic Radiation Sensitivity in Cancer Patients
Recruiting
- Nasopharyngeal Cancer
- +2 more
-
Singapore, SingaporeNational Cancer Center Singapore
Dec 1, 2022
Sarcopenia, Cirrhosis, Liver Trial in Dublin (Amino MP9)
Recruiting
- Sarcopenia
- Cirrhosis, Liver
- Amino MP9
-
Dublin, IrelandRoyal College of Surgeons in Ireland
Apr 26, 2022
After Conversion to Belatacept in Renal Transplant Patients
Not yet recruiting
- Renal Transplant
- Conversion
- Blood sample
- urinary sample
-
Tours, FranceUniversity hospital
Jan 26, 2023
From Lung and Blood Samples in Suspected Lung Cancer
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Bronchoscopic Biopsy
- Blood Sample
-
Farmington, Connecticut
- +4 more
Aug 17, 2022
Atopic Dermatitis: Sub-Saharan Africa vs. Central Europe
Recruiting
- Atopic Dermatitis
- Observation
-
Zürich, Switzerland
- +1 more
Aug 3, 2022
Stress, Healthy, Dietary Supplement Trial in Szczecin (Pasteurized Akkermansia muciniphila, Placebo)
Not yet recruiting
- Stress
- +2 more
- Pasteurized Akkermansia muciniphila
- Placebo
-
Szczecin, Zachodniopomorskie, PolandPomeranian Medical University in Szczecin
Feb 12, 2023
Hypersensitivity, Hay Fever, Rhinitis, Allergic, Seasonal Trial (Polvac Grass+Rye)
Not yet recruiting
- Hypersensitivity
- +3 more
- Polvac Grass+Rye
- (no location specified)
Jul 17, 2023
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023
Systemic Lupus Erythematous (SLE) Trial run by the NIAMS (SOLU-MEDROL)
Recruiting
- Systemic Lupus Erythematous (SLE)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Cigarette Smoking-Related Carcinoma, Lung Carcinoma Trial in Columbus (procedure, biological, other)
Not yet recruiting
- Cigarette Smoking-Related Carcinoma
- Lung Carcinoma
- Biospecimen Collection
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 6, 2023
HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)
Active, not recruiting
- HepatoCellular Carcinoma
- Y-90 Radioembolization
- Nivolumab
-
Singapore, SingaporeNational Cancer Centre - Singapore
May 25, 2022
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Recruiting
- Recurrent Prostate Cancer
- Biopsy
-
New York, New YorkColumbia University Medical Center
Mar 22, 2022
Surgical Recovery, Pain, Postoperative Trial in Stanford (N-acetyl cysteine, Normal Saline)
Enrolling by invitation
- Surgical Recovery
- Pain, Postoperative
- N-acetyl cysteine
- Normal Saline
-
Stanford, CaliforniaStanford University School of Medicine
Dec 7, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Mesothelioma Trial in Houston (MEDI4736, Tremelimumab, no other name)
Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta
Recruiting
- Metastatic Non-Small Lung Cell Cancer
- +4 more
- Docetaxel
- +2 more
-
Atlanta, GeorgiaWinship Cancer Institute of Emory University
Oct 19, 2022
Province of Ontario Strategy for Personalized Management of
Recruiting
- Pancreas Cancer
- Non-interventional
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jun 21, 2023